3-hydroxybutyric acid has been researched along with rosiglitazone in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chisholm, DJ; Jenkins, AB; Kennedy, CJ; Kraegen, EW; Laybutt, DR; Oakes, ND | 1 |
1 other study(ies) available for 3-hydroxybutyric acid and rosiglitazone
Article | Year |
---|---|
A new antidiabetic agent, BRL 49653, reduces lipid availability and improves insulin action and glucoregulation in the rat.
Topics: 3-Hydroxybutyric Acid; Adipose Tissue; Adipose Tissue, Brown; Animals; Biological Availability; Blood Glucose; Dietary Carbohydrates; Dietary Fats; Fatty Acids, Nonesterified; Glucose; Glucose Clamp Technique; Glycerol; Heart; Hydroxybutyrates; Hypoglycemic Agents; Insulin; Insulin Resistance; Lipid Metabolism; Liver; Liver Glycogen; Male; Muscles; Myocardium; Rats; Rats, Wistar; Rosiglitazone; Thiazoles; Thiazolidinediones; Triglycerides | 1994 |